Serafilcon A contact lenses
DeviceReusable silicone hydrogel contact lenses worn during the day and removed at night for cleaning and disinfection
Other names: LID022821
NCT Number: NCT05766787
The purpose of this study is to assess the clinical performance of two reusable silicone hydrogel contact lenses when worn on a daily wear basis.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Kurata Eyecare Center, Los Angeles, California, United States
In this crossover study, subjects will wear each lens product for approximately 14 days and attend 7 scheduled visits. The expected overall duration of exposure to the study products is approximately 28 days.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Reusable silicone hydrogel contact lenses worn during the day and removed at night for cleaning and disinfection
Other names: LID022821
Reusable silicone hydrogel contact lenses worn during the day and removed at night for cleaning and disinfection
Other names: ACUVUE OASYS® with HYDRACLEAR® PLUS Technology, AOHP
Hydrogen peroxide based contact lens cleaning and disinfecting solution
Other names: CLEAR CARE® Cleaning and Disinfecting Solution
Time frame: Week 1 of each lens product worn during the corresponding crossover period
Visual acuity (VA) was assessed for each eye individually with study lenses in place using logarithmic of the Minimum Angle of Resolution (logMAR) reading charts. LogMAR values typically range from -0.3 (20/10 vision on the Snellen chart) to 1 (20/200 vision). A logMAR acuity of 0.0 corresponds to 20/20 Snellen acuity (normal distance visual acuity), with a negative value denoting better than 20/20 visual acuity.
Alcon Research
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05790928
Eye Diseases, Hyperopia
Tallahassee, Florida, United States
View Trial DetailsNCT04013789
Asthenopia, Eye Diseases
Bloomington, Indiana, United States
View Trial DetailsNCT07696468
Eye Diseases, Myopia
Guangzhou, Guangdong, China
View Trial DetailsNCT07512102
Eye Diseases, Myopia
Guangzhou, Guangdong, China
View Trial Details